Tetrahydroisoquinoline-and tetrahydrobenzazepine derivatives as IGF-1R inhibitors

Details for Australian Patent Application No. 2004317166 (hide)

Owner Analytecon S.A.

Inventors Gunzinger, Jan; Leander, Kurt

Agent Wrays

Pub. Number AU-B-2004317166

PCT Pub. Number WO2005/087743

Filing date 12 March 2004

Wipo publication date 22 September 2005

Acceptance publication date 11 November 2010

International Classifications

C07D 217/14 (2006.01) Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

A61K 31/472 (2006.01) - Non-condensed isoquinolines, e.g. papaverine

A61K 31/4725 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07D 217/16 (2006.01) Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

C07D 233/16 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

31 August 2006 PCT application entered the National Phase

  PCT publication WO2005/087743 Priority application(s): WO2005/087743

11 November 2010 Application Accepted

  Published as AU-B-2004317166

10 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004317168-A light hydrocarbon fuel, the method and apparatus for its gasification

2004317165-Polynucleotides for the detection of escherichia coli O157